Novel heteroaryl peptidomimetics as thrombin receptor antagonists
    3.
    发明申请
    Novel heteroaryl peptidomimetics as thrombin receptor antagonists 失效
    新型杂芳基肽模拟物作为凝血酶受体拮抗剂

    公开(公告)号:US20060009396A1

    公开(公告)日:2006-01-12

    申请号:US11227504

    申请日:2005-09-15

    IPC分类号: A61K38/05 C07K5/06

    CPC分类号: C07K5/06191 C07K5/06095

    摘要: The invention is directed to novel heteroaryl peptidomimetic compounds which are useful as thrombin receptor antagonists for the treatment of diseases associated with thrombosis, restenosis, hypertension, heart failure, arrhythmia, inflammation, angina, stroke, atherosclerosis, ischemic conditions, angiogenesis and related disorders, cancer, and neurodegenerative disorders. Pharmaceutical compositions comprising the substituted heteroaryl peptidomimetics of the present invention and methods of treating conditions mediated by the thrombin receptor are also disclosed.

    摘要翻译: 本发明涉及可用作凝血酶受体拮抗剂用于治疗与血栓形成,再狭窄,高血压,心力衰竭,心律失常,炎症,心绞痛,中风,动脉粥样硬化,缺血性疾病,血管生成和相关疾病相关的疾病的新型杂芳族肽模拟化合物, 癌症和神经变性疾病。 还公开了包含本发明的取代的杂芳基肽模拟物的药物组合物和治疗由凝血酶受体介导的病症的方法。